Abstract I In nt tr ro od du uc ct ti io on n. . The influence of chronic administration of losartan on gap junction conductance (gj), conduction velocity and interstitial fibrosis was investigated in the failing heart of 4-month-old cardiomyopathic hamsters (TO-2).After two months of administration of losartan (25 mg/kg/day/po) the number of cell pairs showing very low values of gj (2-8 nS) was significantly reduced whereas the group of cell pairs with larger values of gj (18-45 nS) was significantly increased.The conduction velocity measured with intracellular microelectrodes in the wall of the left ventricle was enhanced from 38 + 2.3 cm/s (n=25) (control) to 49 + 2 cm/s (n=24) (p<0.05) after losartan administration. Moreover, the number of ventricular fibres showing non-propagated action potentials was significantly decreased (p<0.05) by losartan.The % area of interstitial fibrosis measured in the wall of the left ventricle was reduced from 22 + 1.4% (n=18) to 14 + 1.3% (n=18) (p<0.05) after losartan administration. C Co on nc cl lu us si io on n. . Chronic blockade of angiotensin II type 1 receptors increased gj in the failing heart. Moreover, the conduction velocity was enhanced in part by the increase of gj and in part by the decrease of interstitial fibrosis and structural remodelling.
Introduction
Evidence has been presented that the activation of the plasma and cardiac renin angiotensin systems during the process of heart failure is largely responsible for the ventricular remodelling, changes in intercellular communication, impulse propagation and the generation of cardiac arrhythmias. 1, 2 The activation of angiotensin II (Ang II) type 1 receptors (AT 1 ) is involved in the decline of gap junctional conductance (gj) in the failing heart with consequent impairment of impulse conduction. 3, 4 Previous studies performed at an advanced stage of the disease with overt heart failure (11 months of age) indicated a large group of cells with an extremely low value of gj (0.8-2.5 nS) and a second group with gj in the range of 7-40 nS. 3 These findings indicate that the gj is gradually impaired during the development of heart failure.
A subject of seminal importance is the possible influence of chronic blockade of Ang II AT 1 -receptors on gap junction remodelling. In the present work the influence of chronic administration of losartan on gj as well as on conduction velocity and interstitial fibrosis was investigated in the failing heart of cardiomyopathic hamsters.
Methods
Male Syrian cardiomyopathic hamsters (TO-2) at two and four months of age (Biobreeders, MA) were used. The animals were kept at the animal house at constant temperature (24ºC) and humidity following the recommendations of NIH. The animals were maintained on a normal animal diet and tap water ad libitum. Cardiomyopathic animals were divided into two groups. The first group consisted of 2-month-old animals (prehypertrophic stage, n=14) that were treated with losartan (25 mg/kg/day) for an 8-week period. The drug was administered daily by gavage. The second group (2-month-old animals) was treated with vehicle for an 8-week period and was used as controls. All animals were housed in a temperature-controlled room, on a 12-hour light dark cycle.
Measurements of junctional conductance
Cell pairs were obtained by enzymatic dispersion of hamster ventricles following the method of Powell and Twist 5 and Tanigushi et al. 6 The heart was removed with the animals under deep anaesthesia and immediately perfused with a modified Krebs solution containing (mM): NaCl -150; KCl -4; CaCl 2 -2; MgCl -1; CsCl -2; BaCl 2 -1; glucose 5; HEPES -5, pH adjusted to 7.4. After 20 min, a calcium free solution containing 0.4% collagenase (Worthington Biochemical Corp) was recirculated through the heart for 40-60 min. The collagenase solution was washed out with a recovery solution containing (mM): taurine-10; oxalic acid 10; glutamic acid 70; KC l25; KH 2 PO 4 10; glucose 11; pH adjusted to 7.4. All solutions were oxygenated with 100% O 2 . Ventricles were minced (1-2 mm thick slices) and the resulting solution was agitated gently with a
Pasteur pipette. The suspension was filtered through a nylon gauze and the filtrate was centrifuged 4 minutes at 22g. The pellets were resuspended in normal Krebs solution. All experiments were made at 36°C.
Suction pipettes were pulled from microhematocrit tubing by means of a controlled puller (Narishige) and their tips polished with a microforge (Narishige). The pipettes, which were prepared immediately before the experiments, were filled with the following solution (mM): CsCl 110; NaCl 10; TEA 10; MgCl 2 1; CaCl 2 1; EGTA 10; HEPES 5, pH adjusted to 7.3.
Experimental procedure
All experiments were performed in a small chamber mounted on the stage of an inverted phase-contrast microscope (Diaphot, Nikon). The gj was measured using two separated voltage clamp circuits. Gigaohm sealing was achieved in each cell and then the surface membrane of both cells was broken by application of a stronger suction (-35 to -65 cm H 2 O) and a whole cell clamp configuration was produced. Each pipette was connected to a separated voltage clamp amplifier (Axon Instruments, CA) that made it possible to control the non-junctional membrane potential in each cell as well as the voltage gradient across the intercellular junction.
The experimental procedure consisted in holding the membrane potential of both cells at -40 mV. Cell 1 was then pulsed to 0 mV while the membrane of cell 2 was unchanged. Data acquisition and command potentials were controlled with a software program (PCLAMP 8, Axon Instruments).
Since the ratio of series resistance (Rs) to input resistance (IR) is an important factor in the determination of the gj, the experimental protocol was designed to provide a maximised value of IR. This was accomplished by using Cs as a major action on the internal solution and Ba was added to the bath solution to block the potassium conductance. The resistance of the filled pipettes varied from 3-6 MΩ. These procedures resulted in an input resistant of about 2.5-3 GΩ. The pipettes Rs was carefully measured by applying an identical voltage step simultaneously to both cells. The value of Rs was in the range of 6-10 MΩ. The membrane resistance (Rm) was also measured by applying an identical command voltage pulse to both cells at the same time and measuring the steady state currents in both cells. 7 Values of Rm were found to be in the range of 1.5-1.6 GΩ and much higher than the values of Rs. Although Rs did not vary in the majority of the experiments, in two experiments there was a change in Rs and the value of gj was corrected using the following equation 7 The muscle was stimulated with a fine pair of platinum electrodes (0.3 mm diameter) by using rectangular current pulses generated by an electronic stimulator and isolation unit (Grass Instruments, Boston). The intensity of current pulses was twice threshold and the duration of the pulses was 3 ms. Voltage calibration was determined by injecting known voltages between Krebs solution and ground.
Determination of the % area of interstitial fibrosis
To determine the presence of fibrosis coronal sections taken from the equator of the heart were obtained and immediately fixed in formalin (10%). Some sections were stained with haematoxylin-eosin and other with Sirius red or Masson for the study of interstitial fibrosis. Connective tissues and muscle areas were manually traced using a digitised pad connected to a computer. The area fraction of interstitial fibrosis was calculated as the sum of all connective tissue areas divided by the sum of all connective and muscle areas in the field. Tissues were analysed using a LSM 5 Pascal Confocal System, Carl Zeiss (Microimaging, Inc). Measurements of % of fibrosis were performed using a MCID (MicroComputer Imaging Device, Amersham Biosciences, Canada).
Drugs
Losartan was from Merck Sharp and Dohme.
Statistical analysis
Data are mean + SEM. Statistical significance for changes in conduction velocity, interstitial fibrosis and transmembrane potentials was determined with analysis of variance (ANOVA) and defined as a value of p<0.05. Since measurements of gj were clearly separated into two groups (high and low gj) the Fisher's exact probability test was used.
showed a relatively large number of cells weakly coupled. Two major populations of cell pairs with respect to the values of gj were found; one in the range of 2 to 8 nS and the other with higher values of gj (18-45 nS) (figure 1). Since the value of Rs was in the range of 6-10 MΩ, it is reasonable to assume that the values of gj for these cell pairs are underestimated by about 5%. 7 Since Ang II reduces gj in the failing heart 3 the question whether chronic blockade of AT 1 -receptors reverses the gradual decline of gj during the process of heart failure merits serious consideration.
To investigate this possibility, 2-month-old cardiomyopathic hamsters were treated with losartan (25 mg/kg/day) for a period of 8 weeks. At the end of this period, the animals were anaesthetised and the heart was removed under deep anaesthesia. Measurements of gj were performed in isolated cell pairs as described above.
The results showed that the number of cells with very low values gj (2-8 nS) was significantly reduced by losartan while the group with larger values of gj (18-45 nS) was significantly increased as shown in figure 1 . Measurements of gj performed in control hamsters (F1B) showed no significant changes in gj (n=12) (p>0.05) after treatment with losartan (25 mg/kg/day) for a period of eight weeks.
An electrophysiological exploration performed in the isolated left ventricular wall with intracellular microelectrodes indicated a significant decrease of the number of fibres showing non-propagated action potentials when compared with agematched controls (figure 2). Moreover, the conduction velocity measured in the longitudinal direction, was significantly increased in the animals treated with losartan as shown in figure 3 .
Losartan decreases the % area of interstitial fibrosis
Confocal microscopy performed on the heart of cardiomyopathic hamsters at four months of age, showed interstitial fibrosis and severe separation of muscle fibres. Measurements of % area of fibrosis in the left ventricle was performed on the heart of animals treated with losartan for two months and the results were compared with agematched controls. As shown in figure 4 the drug reduced the area of fibrosis from 22 + 1.4% (control) (n=18) to 14 + 1.3% (n=18) (p<0.05) after drug administration.
Discussion
It is known that overexpression of Ang II AT 1 -receptor transgene in the mouse myocardium causes myocyte hyperplasia and heart block. 8 The present results provide evidence, by the first time, that chronic blockade of Ang II AT 1 -receptors reduced gap junction remodelling in the failing heart and increased the values of gj. Indeed, after 
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two months of treatment with losartan the number of cell pairs showing lower values of gj (2-8 nS) was significantly reduced while a second group of cell pairs with greater values of gj (18-45 nS) was significantly enhanced. Therefore, the chronic blockade of AT 1 -receptors can prevent the continuous deterioration of cell coupling during the progress of heart failure and improve the impulse propagation through the failing ventricle with a consequent decrease in the incidence of re-entrant rhythms. The lack of action of losartan on control animals is probably related to the fact that in these the reninangiotensin system (RAS) is not activated.
Previous studies performed on 4-month-old animals, which represent the hypertrophic stage of the disease, not exposed to the drug, indicated the presence of areas in the ventricular wall of non-propagated action potentials, 9 a phenomenon probably related to morphologic remodelling. Of particular interest was the finding that losartan reduced significantly the number of fibres showing non-propagated action potentials.
This beneficial effect of the drug seems related to a decline of interstitial fibrosis with consequent increase of the spread of electrical activity in longitudinal and transversal propagation. Evidence is available that Ang II causes cardiac fibrosis, 10 an effect mediated by AT 1 -receptor activation and TGF-β1 synthesis. 11 Since interstitial fibrosis causes rupture of cell contacts in the ventricle of cardiomyopathic hamsters 12,4 it is reasonable to assume that the disruption of intercellular space impairs or suppresses the flow of current through gap junctions. Therefore, the improvement of cell coupling achieved with losartan might be, in part, related to the decrease of interstitial fibrosis. Supporting this view is the evidence already available that AT 1 -receptor antagonists can prevent the promotion of atrial fibrillation by suppressing the development of structural remodelling. 13, 14 In other studies 15 it was found that losartan (25 mg/kg/day/po) plus hydrochlorothiazide (6.5 mg/kg/day/po) administered for a period of eight weeks, reduced the arterial blood pressure and the heart-to-body mass ratio. However, hydrochlorothiazide alone did not reduce cardiac remodelling despite the reduction in blood pressure. 15 The mechanism by which losartan increased the gj is probably multifactorial. Ang II, for instance, is known to activate different intracellular pathways such as protein kinase C (PKC) and tyrosine kinases 3, 16 with consequent phosphorylation of junctional proteins and decrease of gj. 16 Moreover, the activation of tyrosine kinases is involved in the effects of Ang II in different systems, 17 which supports the notion that the suppression of AT 1 activation and consequent decrease of phosphorylation of junctional proteins elicited by losartan might represent an important factor in the effect of the drug on cell communication. Although it is known that the activation of AT 1 -receptors can activate tyrosine kinases the mechanism involved is not clear. In some cases, however, Ca 2+ and PKC are involved. 18 Since it is known that high enough intracellular calcium can uncouple gap junction channels 19 and that Ang II increases Ca 2+ i, 9 an additional mechanism for the action of losartan might be a possible decrease of the intracellular calcium concentration.
In the failing heart, Northern and Western blot analysis demonstrated a marked decrease of connexin 43 transcript and protein. 20 Therefore, an improvement of expression and distribution of the connexin 43 due to chronic losartan administration, might contribute to the improvement of cell coupling found with the drug. This view is supported by the finding that in hypertrophied ventricles of rats under pressure overload the decrease in number of Cx43 and its abnormal distribution was reversed by losartan. 21 In vitro studies performed on cultured neonatal cardiomyocytes submitted to chronic administration of Ang II showed, however, increased expression of 
. 22, 23 Although the reason for this difference is not known, neonatal cardiac cells seem to be quite different from adult differentiated myocytes. Indeed, Saris et al. 24 were unable to detect Ang II generation in neonatal cardiomyocytes after addition of prorenin to the medium.
Finally, considering that the activation of an intracrine RAS is involved in the regulation of cell communication in the failing heart 3 and that intracellular Ang II generated inside the cell or internalised into cardiac myocytes, causes cell uncoupling, 2, 3 it is reasonable to assume that a greater beneficial effect would be achieved if the intracellular effect of Ang II is blocked. Evidence is available that there is an intracellular Ang II receptor 3, 25 and that intracellular administration of losartan suppresses the effect of Ang II on cell coupling. 25 Therefore, an important pharmacological approach for treatment of heart failure might be to block the intracellular effect of Ang II together with the blockade of its effect on AT 1 -receptors located at surface cell membrane. The generation of drugs with the ability to suppress the intracellular action of Ang II might represent an important step in the treatment of heart failure.
In conclusion, the chronic blockade of Ang II AT 1 -receptors increased impulse propagation in the failing heart in part by increasing the gj and in part by reducing interstitial fibrosis and structural remodelling. 
